On August 12th, Nikko published a report stating that BeiGene's second-quarter revenue increased by 56% YoY to $0.929 billion, 16% higher than the market forecast, due to strong sales of Brukinsa. Nikko has raised BeiGene's revenue forecast for 2024 to 2026 by 13% to 16%, mainly due to the upward adjustment of Brukinsa's sales forecast. In addition, the bank has raised its target price from HKD 155 to HKD 162 and rated it a "buy".
大行评级｜大和：上调百济神州目标价至162港元 上调2024至26年营收预测
Daiwa Rating: Daiwa has raised the target price of BeiGene to HKD 162 and increased the revenue forecast for 2024-2026.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.